These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
396 related items for PubMed ID: 33715177
1. Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti-TNF-α: results from the ENEIDA registry. Mesonero F, Castro-Poceiro J, Benítez JM, Camps B, Iborra M, López-García A, Torres P, Esteve M, Tosca J, Bertoletti F, Almela P, Calvet X, Vera I, Bujanda L, Gomollón F, Rodríguez C, Antolín B, Busquets D, Hernández A, Rivero M, Monfort I Miquel D, Castaño-García A, Gisbert JP, Domènech E, López-Sanromán A, ENEIDA Project of GETECCU. Aliment Pharmacol Ther; 2021 May; 53(9):1021-1029. PubMed ID: 33715177 [Abstract] [Full Text] [Related]
2. Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry. García MJ, Rivero M, Fernández-Clotet A, de Francisco R, Sicilia B, Mesonero F, de Castro ML, Casanova MJ, Bertoletti F, García-Alonso FJ, López-García A, Vicente R, Calvet X, Barreiro-de Acosta M, Ferrer Rosique J, Varela Trastoy P, Nuñez A, Ricart E, Riestra S, Arias García L, Rodríguez M, Arranz L, Pajares R, Mena R, Calafat M, Camo P, Bermejo F, Ponferrada Á, Madrigal RE, Llaó J, Sesé E, Sánchez E, Pineda Mariño JR, González Muñoza C, Carbajo López AY, Julián AB, Villoria Ferrer A, Baston-Rey I, Jara L, Almela P, Codesido L, de la Maza S, Leal C, Caballol B, Pérez-Martínez I, Vinuesa Campo R, Crespo J, Domènech E, Chaparro M, Gisbert JP. J Crohns Colitis; 2024 Jan 27; 18(1):65-74. PubMed ID: 37522878 [Abstract] [Full Text] [Related]
3. Methotrexate for induction of remission in refractory Crohn's disease. McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG. Cochrane Database Syst Rev; 2012 Dec 12; 12():CD003459. PubMed ID: 23235598 [Abstract] [Full Text] [Related]
4. Parenteral Methotrexate Is Efficient in the Treatment of Azathioprine Refractory Crohn's Disease. Gökbulut V, Özin Y, Kalkan İH, Arı D, Yüksel M, Kılıç ZMY, Kayaçetin E. Turk J Gastroenterol; 2022 Feb 12; 33(2):111-118. PubMed ID: 35115294 [Abstract] [Full Text] [Related]
5. Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease: a controlled pilot study. Schröder O, Blumenstein I, Stein J. Eur J Gastroenterol Hepatol; 2006 Jan 12; 18(1):11-6. PubMed ID: 16357613 [Abstract] [Full Text] [Related]
6. Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study. Haisma SM, Lijftogt T, Kindermann A, Damen G, de Ridder L, Escher JC, Mearin ML, de Meij T, Hendriks D, George E, Hummel T, Norbruis O, van Rheenen P. J Crohns Colitis; 2015 Apr 12; 9(4):305-11. PubMed ID: 25656249 [Abstract] [Full Text] [Related]
7. Real-world long-term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry. Iborra M, Beltrán B, Fernández-Clotet A, Iglesias-Flores E, Navarro P, Rivero M, Gutiérrez A, Sierra-Ausin M, Mesonero F, Ferreiro-Iglesias R, Hinojosa J, Calvet X, Sicilia B, González-Muñoza C, Antolín B, González-Vivo M, Carbajo AY, García-López S, Martín-Cardona A, Surís G, Martin-Arranz MD, de Francisco R, Cañete F, Domènech E, Nos P, GETECCU group (Grupo Español de trabajo de Enfermedades de Crohn y Colitis Ulcerosa). Aliment Pharmacol Ther; 2020 Sep 12; 52(6):1017-1030. PubMed ID: 32770851 [Abstract] [Full Text] [Related]
8. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series. Absah I, Faubion WA. Inflamm Bowel Dis; 2012 Aug 12; 18(8):1488-92. PubMed ID: 21882301 [Abstract] [Full Text] [Related]
9. Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry. Salazar J, Garcia-Planella E, Fernández-Clotet A, Esteve M, Gisbert JP, Busquets D, Lucendo A, Márquez L, Guardiola J, Martín-Arranz MD, Iglesias E, Monfort D, Villoria A, Cañete F, Bell O, Ricart E, Zabana Y, Chaparro M, Domènech E, Gordillo J, ENEIDA registry of GETECCU. Br J Clin Pharmacol; 2024 May 12; 90(5):1301-1311. PubMed ID: 38369687 [Abstract] [Full Text] [Related]
10. Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registry. Iborra M, Beltrán B, Fernández-Clotet A, Gutiérrez A, Antolín B, Huguet JM, De Francisco R, Merino O, Carpio D, García-López S, Mesonero F, Navarro P, Ferreiro-Iglesias R, Carbajo AY, Rivero M, Gisbert JP, Piñero-Pérez MC, Monfort D, Bujanda L, García-Sepulcre MF, Martín-Cardona A, Cañete F, Taxonera C, Domènech E, Nos P, GETECCU Group (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa). Aliment Pharmacol Ther; 2019 Aug 12; 50(3):278-288. PubMed ID: 31222872 [Abstract] [Full Text] [Related]
11. [Anti-TNF therapy in treatment of luminal Crohn's disease]. Marko B, Prka L. Acta Med Croatica; 2013 Apr 12; 67(2):179-89. PubMed ID: 24471301 [Abstract] [Full Text] [Related]
12. Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease. Vasudevan A, Raghunath A, Anthony S, Scanlon C, Sparrow MP, Gibson PR, van Langenberg DR. Dig Dis Sci; 2019 Jun 12; 64(6):1622-1631. PubMed ID: 30560332 [Abstract] [Full Text] [Related]
13. Methotrexate for induction of remission in refractory Crohn's disease. Alfadhli AA, McDonald JW, Feagan BG. Cochrane Database Syst Rev; 2003 Jun 12; (1):CD003459. PubMed ID: 12535475 [Abstract] [Full Text] [Related]
14. Methotrexate for induction of remission in refractory Crohn's disease. Alfadhli AA, McDonald JW, Feagan BG. Cochrane Database Syst Rev; 2005 Jan 25; (1):CD003459. PubMed ID: 15674908 [Abstract] [Full Text] [Related]
15. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited? Charpignon C, Beau P. Gastroenterol Clin Biol; 2008 Feb 25; 32(2):153-7. PubMed ID: 18343615 [Abstract] [Full Text] [Related]
16. Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn's Disease. Savelkoul EHJ, Maas MHJ, Bourgonje AR, Crouwel F, Biemans VBC, den Broeder N, Russel MGVM, Römkens TEH, de Boer NK, Dijkstra G, Hoentjen F. J Crohns Colitis; 2022 Sep 08; 16(9):1372-1379. PubMed ID: 35303065 [Abstract] [Full Text] [Related]
17. Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease. Walters TD, Kim MO, Denson LA, Griffiths AM, Dubinsky M, Markowitz J, Baldassano R, Crandall W, Rosh J, Pfefferkorn M, Otley A, Heyman MB, LeLeiko N, Baker S, Guthery SL, Evans J, Ziring D, Kellermayer R, Stephens M, Mack D, Oliva-Hemker M, Patel AS, Kirschner B, Moulton D, Cohen S, Kim S, Liu C, Essers J, Kugathasan S, Hyams JS, PRO-KIIDS Research Group. Gastroenterology; 2014 Feb 08; 146(2):383-91. PubMed ID: 24162032 [Abstract] [Full Text] [Related]
18. Methotrexate for the treatment of refractory Crohn's disease. Lémann M, Chamiot-Prieur C, Mesnard B, Halphen M, Messing B, Rambaud JC, Gendre JP, Colombel JF, Modigliani R. Aliment Pharmacol Ther; 1996 Jun 08; 10(3):309-14. PubMed ID: 8791956 [Abstract] [Full Text] [Related]
19. Methotrexate for maintenance of remission in Crohn's disease. Patel V, Macdonald JK, McDonald JW, Chande N. Cochrane Database Syst Rev; 2009 Oct 07; (4):CD006884. PubMed ID: 19821390 [Abstract] [Full Text] [Related]
20. Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience. Peyrin-Biroulet L, Salleron J, Filippi J, Reenaers C, Antunes O, Filipe V, Louis E, Hébuterne X, Roblin X. J Crohns Colitis; 2016 May 07; 10(5):516-24. PubMed ID: 26802084 [Abstract] [Full Text] [Related] Page: [Next] [New Search]